Skip to main content
Premium Trial:

Request an Annual Quote

Miraculins Hopes to Generate Up to $500K in Equity Placement

NEW YORK (GenomeWeb News) — Miraculins yesterday said it plans to generate as much as $500,000 through a private stock placement.
The company plans to use the proceeds to fund research and development projects, and for working capital purposes.
Miraculins will offer as many as 1.25 million equity “units” for $.40 apiece. Each unit will include one common company share and one half of one share purchase warrant, which will be set at $.65 for a 12-month period from the date the offering closes.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.